"I like BTA, it is well funded on a general upcurve and has just completed a successful software application in hospitals in Asia. A recent impressive capital raising and a program to include shareholders should not dilute the share price, the US government's move to shore up public funding for medicine should lead to oportunities in the health services sector."
A fine example of why beating the market average is easy to do. Competing against people with that kind of knowledge is as easy as fishing with dynamite. I've heard of mixed metaphors, but this is some crazy mixed analysis.
By the way I agree with abobo's interpretation of the GSK "options".
BTA Price at posting:
58.5¢ Sentiment: None Disclosure: Held
